• Donate
  • Contact
Canadian Association of Pompe
  • Home
  • About Us
    • Personal Stories
    • Newsletter
  • About Pompe
  • Blog
  • Links
  • Connections
Select Page
First gene therapy trial launched for Fabry disease

First gene therapy trial launched for Fabry disease

by CAP | Feb 18, 2013 | Press Releases

CALGARY, AB, Jan. 24, 2013 — Researchers in Calgary have launched the first gene therapy clinical trial in the world for Fabry disease that could ultimately lead to a permanent cure.

Recent Posts

  • Sarepta Therapeutics Enters into a Strategic Relationship with Aldevron in Support of Their Gene Therapy Program
  • CAP Walks for Muscular Dystrophy in 2018
  • Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Study of AT-GAA in Patients with Pompe Disease
  • Audentes Therapeutics Pompe Program Update
  • Amicus Therapeutics Enters Research and Development Collaboration with University of Pennsylvania to Develop AAV Gene Therapies
  • Terms
  • Privacy

Copyright © 2006 - 2019 Canadian Association of Pompe | Developed by PacificByte